For the immunocompetent group, although there was no statistically significant difference in tumor size, we identified numerically increased tumor volumes in B16-C8KO-bearing mice, implicating an immuno-dependent mechanism of Casp8-mediated antitumor immunity (Fig. 2b). This evidence concerns the gene CASP8 and neoplasm.